Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Jessica Blavignac"'
Autor:
Sean Wharton, Errol Gould, Peter Yin, Fernando Camacho, Elham Kamran, Melonie Burrows, Jessica Blavignac, Maxime Barakat, Rebecca A. G. Christensen
Publikováno v:
International Journal of Obesity (2005)
Background Extended-release naltrexone/bupropion (NB) is indicated for chronic weight management. Incretin agents are recommended for patients with type 2 diabetes. This analysis looked at the add-on of NB to incretins to see if weight loss could occ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9bb223e5f6fd23a9f353bc1a7325bb37
https://doi.org/10.1038/s41366-021-00831-4
https://doi.org/10.1038/s41366-021-00831-4
Autor:
Sean, Wharton, David, Macklin, Marie-Philippe, Morin, Jessica, Blavignac, Stuart, Menzies, Laura, Garofalo, Michelle A, Francisco, Carol, Thomas, Maxime, Barakat
Publikováno v:
BMC Primary Care. 23
Background Obesity is a chronic problem in Canada and although the Canadian Medical Association recognizes obesity as a disease, health care professionals (HCPs) are not necessarily proactively managing it as one. This study aimed to assess current o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78dcad2e4ba4f49c97f786b07b06855a
https://doi.org/10.1186/s12875-022-01715-w
https://doi.org/10.1186/s12875-022-01715-w
Autor:
Emilia Paron, Melonie Burrows, Jessica Blavignac, Ronald Goldenberg, Nadege Fils-Aimé, Alan Bell, Will Cheng, Maxime Barakat
Publikováno v:
Journal of Cardiology. 76:385-394
Background Regional differences in the profile and treatment strategies of patients with cardiometabolic diseases have been studied in several different countries. The Cardio-Vascular and metabolic treatments in Canada: Assessment of REal-life therap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b139d08c5c9699b21f9d5e613874874b
https://doi.org/10.1016/j.jjcc.2020.04.008
https://doi.org/10.1016/j.jjcc.2020.04.008
Autor:
Emilia Paron, Willoon Cheng, Jessica Blavignac, Ronald Goldenberg, Alan Bell, Fils-Aimé Nadège, Melonie Burrows, Maxime Barakat
Publikováno v:
Journal of Hypertension and Management. 6
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f0eb3bb5ec5f71ed1653ca603a7bf6b4
https://doi.org/10.23937/2474-3690/1510053
https://doi.org/10.23937/2474-3690/1510053
Autor:
Emilia Paron, Errol Gould, Jessica Blavignac, Roger S. McIntyre, Fernando Camacho, Melonie Burrows, Maxime Barakat
Publikováno v:
Journal of affective disorders. 289
There is significant association between obesity and depression. Naltrexone/Bupropion (NB) is indicated for treatment of overweight and obesity (BMI ≥27 kg/m2 with a comorbidity or ≥30 kg/m2). This post-hoc analysis examines safety and efficacy o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7fb606001ed3b0e04fabb1e81711a0ba
https://pubmed.ncbi.nlm.nih.gov/33989969
https://pubmed.ncbi.nlm.nih.gov/33989969
Autor:
Maxime Barakat, Emilia Paron, Jessica Blavignac, Harpreet S. Bajaj, Melonie Burrows, Errol Gould, Fernando Camacho
Publikováno v:
Diabetes, obesitymetabolismREFERENCES. 23(3)
Sustained weight loss improves liver histology in non-alcoholic fatty liver disease. This post-hoc analysis of four phase III, 56-week, randomized, controlled trials investigated if extended-release naltrexone and bupropion (NB) affects alanine amino
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cfbc4f36125ff6cee895b25bfe0c8ede
https://pubmed.ncbi.nlm.nih.gov/33275326
https://pubmed.ncbi.nlm.nih.gov/33275326
Autor:
Fernando Camacho, Jessica Blavignac, Peter Yin, Maxime Barakat, Melonie Burrows, Sean Wharton
Publikováno v:
Diabetes. 69
There is significant overlap between obesity and type 2 diabetes (T2DM). Incretin agents (dipeptidyl peptidase 4 (DPP-4) inhibitors and glucagon-like peptide 1 receptor agonists (GLP-1RAs)) are recommended as second-line to metformin in patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3ab2d9d77cc16021aafc9dd0d7787138
https://doi.org/10.2337/db20-141-or
https://doi.org/10.2337/db20-141-or
Autor:
Emilia Parron, Melonie Burrows, Willoon Cheng, Alan Bell, Maxime Barakat, Ronald Goldenberg, Nadege Fils-Aimé, Jessica Blavignac
Publikováno v:
Diabetes Research and Clinical Practice. 170:108416
Aims The CV-CARE registry provides RWE in Canadian routine clinical practice. Methods CV-CARE is a multi-site, observational, prospective Canadian registry enrolling patients initiating treatment with metformin hydrochloride extended-release (MetER)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f1c6532fc7afef1ca19742dc9b29d64
https://doi.org/10.1016/j.diabres.2020.108416
https://doi.org/10.1016/j.diabres.2020.108416
Autor:
Monique Giguere, Ronald Goldenberg, Jessica Blavignac, Angela Karellis, Willoon Cheng, Maxime Barakat, Alan Bell, John S. Sampalis, Jean-Francois Fortin
Publikováno v:
Canadian Journal of Diabetes. 42:S44-S45
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d3ca6ad210d5bc45ce2783c5d4505b8a
https://doi.org/10.1016/j.jcjd.2018.08.132
https://doi.org/10.1016/j.jcjd.2018.08.132
Autor:
Maria Diamandis, Andrew D. Paterson, Isidro Wong, Bhupinder Bharaj, Georges E. Rivard, Johanna M. Rommens, John S. Waye, Jessica Blavignac, Catherine P.M. Hayward
Publikováno v:
Blood. 115:1264-1266
Quebec platelet disorder (QPD) is an autosomal dominant bleeding disorder linked to a region on chromosome 10 that includes PLAU, the urokinase plasminogen activator gene. QPD increases urokinase plasminogen activator mRNA levels, particularly during
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b8d7132e6146b6ac3ff5e0751d1ddd2
https://doi.org/10.1182/blood-2009-07-233965
https://doi.org/10.1182/blood-2009-07-233965